146 related articles for article (PubMed ID: 2435101)
21. Immunohistochemical differentiation of malignant mesothelioma, mesothelial hyperplasia and metastatic adenocarcinoma in serous effusions, utilizing staining for carcinoembryonic antigen, keratin and vimentin.
Duggan MA; Masters CB; Alexander F
Acta Cytol; 1987; 31(6):807-14. PubMed ID: 2447718
[TBL] [Abstract][Full Text] [Related]
22. Keratin and carcinoembryonic antigen in exfoliated mesothelial and malignant cells: an immunoperoxidase study.
Walts AE; Said JW; Banks-Schlegel S
Am J Clin Pathol; 1983 Nov; 80(5):671-6. PubMed ID: 6195913
[TBL] [Abstract][Full Text] [Related]
23. Diagnostic efficiency of carcinoembryonic antigen and CA125 in the cytological evaluation of effusions.
Pinto MM; Bernstein LH; Rudolph RA; Brogan DA; Rosman M
Arch Pathol Lab Med; 1992 Jun; 116(6):626-31. PubMed ID: 1616424
[TBL] [Abstract][Full Text] [Related]
24. Keratin, luminal epithelial antigen and carcinoembryonic antigen in human urinary bladder carcinomas. An immunohistochemical study.
Nathrath WB; Arnholdt H; Wilson PD
Pathol Res Pract; 1982; 175(2-3):299-307. PubMed ID: 6190152
[TBL] [Abstract][Full Text] [Related]
25. Immunohistochemical demonstration of keratin 7 in routinely fixed paraffin-embedded human tissues.
van Niekerk CC; Jap PH; Ramaekers FC; van de Molengraft F; Poels LG
J Pathol; 1991 Oct; 165(2):145-52. PubMed ID: 1720817
[TBL] [Abstract][Full Text] [Related]
26. WT1, monoclonal CEA, TTF1, and CA125 antibodies in the differential diagnosis of lung, breast, and ovarian adenocarcinomas in serous effusions.
Zhu W; Michael CW
Diagn Cytopathol; 2007 Jun; 35(6):370-5. PubMed ID: 17497661
[TBL] [Abstract][Full Text] [Related]
27. Patterns of reactivity of four novel monoclonal antibodies (B72.3, DF3, B1.1 and B6.2) with cells in human malignant and benign effusions.
Szpak CA; Johnston WW; Lottich SC; Kufe D; Thor A; Schlom J
Acta Cytol; 1984; 28(4):356-67. PubMed ID: 6205527
[TBL] [Abstract][Full Text] [Related]
28. Immunohistochemical properties of malignant mesothelioma cells in histologic and cytologic specimens.
Motoyama T; Watanabe T; Okazaki E; Tanaka N; Watanabe H
Acta Cytol; 1995; 39(2):164-70. PubMed ID: 7534025
[TBL] [Abstract][Full Text] [Related]
29. Malignant ascites of serous papillary ovarian adenocarcinoma. An immunocytochemical study of the tumor cells.
Guzman J; Hilgarth M; Bross KJ; Ross A; Wiehle U; Kresin V; Grunert F; von Kleist S
Acta Cytol; 1988; 32(4):519-22. PubMed ID: 3041721
[TBL] [Abstract][Full Text] [Related]
30. CEA, ZGM and EMA localization in cells of pleural and peritoneal effusion: a preliminary study.
O'Brien MJ; Kirkham SE; Burke B; Ormerod M; Saravis CA; Gottlieb LS; Neville AM; Zamcheck N
Invest Cell Pathol; 1980; 3(3):251-8. PubMed ID: 6159337
[TBL] [Abstract][Full Text] [Related]
31. [GC12, marker of cells of mesodermal origin. Value and application to cytodiagnosis of serous effusions].
Daste G; Gioanni J; Lauque D; Kremps M; Mazeau C; Paquis P; Schneider M
Arch Anat Cytol Pathol; 1997; 45(4):185-91. PubMed ID: 9406475
[TBL] [Abstract][Full Text] [Related]
32. An immunohistochemical study of the distribution of epithelial antigens in the uterine cervix.
Bamford PN; Ormerod MG; Sloane JP; Warburton MJ
Obstet Gynecol; 1983 May; 61(5):603-8. PubMed ID: 6188081
[TBL] [Abstract][Full Text] [Related]
33. Localization of epithelial markers and defence proteins in minor and major salivary glands.
Vigneswaran N; Haneke E; Hornstein OP; Niedermeier W
Acta Histochem Suppl; 1989; 37():235-9. PubMed ID: 2475885
[TBL] [Abstract][Full Text] [Related]
34. [Use of immunohistochemistry in clinical cytology].
Weintraub D; Weintraub J; Vassilakos P
Ann Pathol; 1987; 7(1):25-30. PubMed ID: 3304314
[TBL] [Abstract][Full Text] [Related]
35. Carcinoembryonic antigen in histopathology: immunoperoxidase staining of conventional tissue sections.
Goldenberg DM; Sharkey RM; Primus FJ
J Natl Cancer Inst; 1976 Jul; 57(1):11-22. PubMed ID: 794493
[TBL] [Abstract][Full Text] [Related]
36. Markers of oral and salivary gland tumors: immunocytochemical investigations.
Seifert G; Caselitz J
Cancer Detect Prev; 1985; 8(1-2):23-34. PubMed ID: 2415254
[TBL] [Abstract][Full Text] [Related]
37. Distinction between hepatocellular carcinoma, cholangiocarcinoma, and metastatic carcinoma based on immunohistochemical staining for carcinoembryonic antigen and for cytokeratin 19 on paraffin sections.
Balaton AJ; Nehama-Sibony M; Gotheil C; Callard P; Baviera EE
J Pathol; 1988 Dec; 156(4):305-10. PubMed ID: 2465399
[TBL] [Abstract][Full Text] [Related]
38. Immunocytochemical differentiation of reactive mesothelial cells and adenocarcinoma cells in serous effusions with the use of carcinoembryonic antigen and fibronectin.
Athanassiadou P; Athanassiades P; Lazaris D; Kyrkou K; Petrakakou E; Aravantinos D
Acta Cytol; 1994; 38(5):718-22. PubMed ID: 8091904
[TBL] [Abstract][Full Text] [Related]
39. Use of a monoclonal antibody (B72.3) as an immunocytochemical adjunct to diagnosis of adenocarcinoma in human effusions.
Johnston WW; Szpak CA; Lottich SC; Thor A; Schlom J
Cancer Res; 1985 Apr; 45(4):1894-900. PubMed ID: 3884146
[TBL] [Abstract][Full Text] [Related]
40. Cytokeratins 7 and 20 and carcinoembryonic antigen in ovarian and colonic carcinoma.
Berezowski K; Stastny JF; Kornstein MJ
Mod Pathol; 1996 Apr; 9(4):426-9. PubMed ID: 8729984
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
